Split-Dose Cisplatin Plus Atezolizumab for Patients With Urothelial Carcinoma Who Are Considered Ineligible for Full Doses of Cisplatin (SOGUG-AUREA) In patients with mRCC, Medicare was associated ...
Please provide your email address to receive an email when new articles are posted on . Insurance status contributes to considerable disparities in care quality for patients with head and neck cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results